Jay R. Luly, President and CEO at ENANTA PHARMACEUTICALS INC (ENTA), sold 15,000 shares at $38.92 ($588K) on 2014-04-01, disclosed to the SEC on 2014-04-02.
Scheduled sale ($588k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.92 | 12,300 | $479K | 81.5% |
| 2 | $40.22 | 2,200 | $88K | 15.1% |
| 3 | $40.71 | 500 | $20K | 3.5% |
| Total | $39.17 avg | 15,000 | $588K | 100% |
| Filing → |
| ENTA | SELL | 2024-12-10 | $41K | — | Filing → |
| ENTA | SELL | 2023-12-06 | $139K | — | Filing → |
| ENTA | SELL | 2023-03-14 | $2.5M | — | Filing → |